NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Vestiage, Inc. (NQB:VEST), the healthy aging company that owns both the RegiMEN™ and Monterey Bay Nutraceuticals™ supplement product lines, announced today that it has appointed Ms. Laura Stall as Vice President, Nutraceuticals Sales, Western Region. Ms. Stall has had a distinguished career in sales to major retailers including Whole Foods and Ralphs grocery stores.
“I am very excited to have Laura join the Vestiage™ family today,” said Scott Kimball, CEO of Vestiage. “We’re fortunate to have a professional with exceptional experience in dealing with the majors in the natural channel and with traditional grocery and drug retailers, distributors, and brokers. This is a great addition to our team that will allow us to grow and build a sales team that covers the United States and drive aggressively into the retail channel. She has very good relationships with precisely the retailers that we want to grow with, and Laura has already worked successfully with our head of nutraceuticals sales, Tom Youngerman, in the past. We feel we are getting a known quantity and an important part of a team that will be the center of our retail sales effort for many years.”
Ms. Stall has over 20 years as a senior level executive with P&L experience in sales and key account management. She has managed brokers, trade marketing, and has experience with strategic planning for major retail relationships. She has been a national account manager for Twining’s Teas of London, where she led corporate business development for the Natural and Grocery channel in the Western US. Prior to Twining’s, she distinguished herself in significant positions at MillerCoors, PepsiCo, Aurora Foods, and Pillsbury.
Ms. Stall will handle all Vestiage™ products in the retail channel; however, she will be the senior executive in charge of the launch and sales of Monterey Bay Nutraceuticals™, a new line which is coming to market after years of collaborative R&D. The Monterey Bay Nutraceuticals™ brand was created by Vestiage™ in partnership with Robinson Pharma, Nutragenesis, and others to create the purest, most effective natural nutraceuticals in the world using the best ingredients, many of them patented, from the earth and the ocean. More can be seen at www.montereybaynutra.com or www.trimandenergized.com.
RegiMEN™ was created by Youngerman and Mayo Clinic trained cardiologist Robert Burke, M.D. The RegiMEN™ brand has 8 products in the line, all scientifically formulated to address the major causes of aging in men. RegiMEN™ is the only complete system of healthy aging products for men. The line includes Testosterone Support, Anti-Inflammatory & Anti-Oxidant Support, Growth Hormone Support, DHEA, Heart Health, Vision Support, and Prostate Health, and a Multi Vitamin/Mineral. All the products are natural, do not have any bio-identical hormones in the formulations, and are designed to support the body's natural production of key hormones, and support the suppression of unwanted hormones (like estrogen) in men as they age. More can be seen at www.buyregimen.com and www.repairlowt.com.
Vestiage™ (NQB:VEST) is a publicly traded healthy aging lifestyle company offering premium branded science-based nutraceuticals and cosmeceuticals. Vestiage™ is focused on the use of human stem cell, marine/ocean, and cutting edge botanically based science and patented ingredients to produce highly potent, elegantly formulated products with clinically proven ingredients. Using high potency and novel ingredient combinations, Vestiage™ creates and distributes multifunctional nutraceuticals such as RegiMEN™ for men (www.BuyRegimen.com) and Monterey Bay Nutraceuticals™ for women (www.MontereyBayNutra.com). Vestiage™ brands address the top “in demand” aging and other concerns of men and women. Vestiage™ research is focused on longevity and human performance science that covers both the cognitive and physical realms. To learn more, visit the Company website, www.vestiageinc.com.
This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.